Chemotherapy Regime Therapy Naming Conventions

Chemotherapy regimens, which are internationally recognized and implemented, are acceptable content and may be added to the (regime/therapy) hierarchy as subtypes of

Trade names, which are indicated by an acronym, e.g. ABVD chemotherapy regimen, where A represents trade name Adriamycin®, should not be spelled out but may be referenced in the acronym used to describe the regimen.

Generic drug names are not capitalized; they are lower case. When creating descriptions for generic drug names, the substance described should match the description from the Substance hierarchy.

• Examples:

  • ABVD chemotherapy regimen. A represents the trade name Adriamycin® (INN = doxorubicin):

    • FSN: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen (regime/therapy)

    • PT: ABVD chemotherapy regimen

    • Synonym: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen

    • Synonym: ABVD chemotherapy protocol 

  • R-CHOP chemotherapy regimen. H represents the non-INN generic name hydroxydaunomycin (INN = doxorubicin) and O represents the trade name Oncovin® (INN = vincristine):

    • FSN: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy)

    • PT: R-CHOP chemotherapy regimen

    • Synonym: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen

    • Synonym: R-CHOP chemotherapy protocol